Why is Warner Bros. Discovery splitting in two?
How will Amazon’s $20B Pennsylvania cloud investment affect AI?
What caused Tesla’s stock downgrades after Musk-Trump feud?
Why did OpenAI hit $10 billion in annual recurring revenue?
How will Trump’s National Guard deployment impact LA protests?
What are the effects of US-China trade talks in London?
Why is Apple redesigning iOS with 'Liquid Glass' interface?
Beyfortus Output Tripled As Sanofi, AstraZeneca Scale Up For RSV Season
benzinga.com/news/health-care/25/06/45839621/beyfortus-output-tripled-as-sanofi-astrazeneca-scale-up-for-rsv-season
French drugmaker Sanofi SA (NASDAQ:SNY) on Monday said it is shipping Beyfortus (nirsevimab) starting in early Q3 to ensure broad availability well ahead of the 2025-2026 respiratory syncytial virus (RSV) season, which typically starts in November and runs through March.
Sanofi, in…
This story appeared on benzinga.com, 2025-06-09 15:00:29.